Greenwood Sejahtera Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Greenwood Sejahtera Tbk. trades at Rp121 (market cap 928.29B, 683.2K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp147 (market cap 576.7B, 3.18M 24h volume). The key difference: Greenwood Sejahtera Tbk. is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.18M versus 683.2K). Which is the better fit depends on your goals.
| GWSA | LABS | |
|---|---|---|
Market Cap | 928.29B | 576.7B |
Volume | 683.2K | 3.18M |
Lot | 6.83K | 31.81K |
Turnover | 82.63M | 478.31M |
Average Price | 120.94 | 150.39 |
Value | 82.63M | 478.31M |
Indicative Equilibrium Price | 124 | 147 |
Indicative Equilibrium Volume | 25 | 311 |
Trailing returns across standard periods
Latest headlines on both assets
Greenwood Sejahtera is part of KG Global Development. On the begining, the company have a relation with Jababeka group, which own the land that has been used to builit TCC Batavia.PT Greenwood Sejahtera, company that developing The City Center Batavia (TCC Batavia), on December 23, 2011. The City Center Batavia is a superblock, mix used development project on top of 2,1 hectares of land. Its first tower is a skycrapper building: a tower with 46 storey, plus an 8 storey annex. According to the masterplan, Greenwood Sejahtera will build 3 tower on the site. The other tower will be completed in 2017 and the area will be expanded to 5.4 hectares. Its ground breaking ceremony is on September 12, 2009.
Read more on GWSA →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →